Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.

Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy. Hum Gene Ther Methods. 2013 Jun; 24(3):151-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.